These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18660702)

  • 21. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
    Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
    J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan in tissue injury and repair.
    Jiang D; Liang J; Noble PW
    Annu Rev Cell Dev Biol; 2007; 23():435-61. PubMed ID: 17506690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of toll-like receptors in solid organ transplantation.
    Obhrai J; Goldstein DR
    Transplantation; 2006 Feb; 81(4):497-502. PubMed ID: 16495791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptors in innate immunity: role of bacterial endotoxin and toll-like receptor 4 in endometrium and endometriosis.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Gynecol Obstet Invest; 2009; 68(1):40-52. PubMed ID: 19365133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor pathways and innate responses to allografts.
    Walker WE; Goldstein DR
    Curr Opin Organ Transplant; 2007 Feb; 12(1):5-9. PubMed ID: 27792082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1.
    McDaniel DO; Zhou X; Moore CK; Aru G
    Transplant Proc; 2010 Dec; 42(10):4235-7. PubMed ID: 21168672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The innate immune system and its relevance to neonatal sepsis.
    Kenzel S; Henneke P
    Curr Opin Infect Dis; 2006 Jun; 19(3):264-70. PubMed ID: 16645488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors in transplantation: sensing and reacting to injury.
    Leventhal JS; Schröppel B
    Kidney Int; 2012 May; 81(9):826-32. PubMed ID: 22297675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors in ischemia-reperfusion injury.
    Arumugam TV; Okun E; Tang SC; Thundyil J; Taylor SM; Woodruff TM
    Shock; 2009 Jul; 32(1):4-16. PubMed ID: 19008778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of toll-like receptors in liver transplantation.
    Howell J; Gow P; Angus P; Visvanathan K
    Liver Transpl; 2014 Mar; 20(3):270-80. PubMed ID: 24243591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE; Xu M; Koski GK; Czerniecki BJ
    Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multiple facets of toll-like receptors in transplantation biology.
    Alegre ML; Leemans J; Le Moine A; Florquin S; De Wilde V; Chong A; Goldman M
    Transplantation; 2008 Jul; 86(1):1-9. PubMed ID: 18622268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of hyaluronan degradation products as innate alloimmune agonists.
    Tesar BM; Jiang D; Liang J; Palmer SM; Noble PW; Goldstein DR
    Am J Transplant; 2006 Nov; 6(11):2622-35. PubMed ID: 17049055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopathogenesis of ischemia/reperfusion-associated tissue damage.
    Ioannou A; Dalle Lucca J; Tsokos GC
    Clin Immunol; 2011 Oct; 141(1):3-14. PubMed ID: 21839685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney.
    Denecke C; Tullius SG
    Prog Urol; 2014 Jun; 24 Suppl 1():S13-9. PubMed ID: 24950927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immune sensing and activation of cell surface Toll-like receptors.
    Tapping RI
    Semin Immunol; 2009 Aug; 21(4):175-84. PubMed ID: 19493685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis.
    Heldin P; Karousou E; Bernert B; Porsch H; Nishitsuka K; Skandalis SS
    Connect Tissue Res; 2008; 49(3):215-8. PubMed ID: 18661346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.